The findings, published in The Lancet medical journal on Friday, showed that, on average, people who got the triple-drug reached the point of no detectable virus five days earlier than those in the control group - at seven days versus 12 days. Aljazeera
Monday, May 11, 2020
Triple anti-viral drug shows COVID-19 promise in Hong Kong study
The findings, published in The Lancet medical journal on Friday, showed that, on average, people who got the triple-drug reached the point of no detectable virus five days earlier than those in the control group - at seven days versus 12 days. Aljazeera
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment